Machine Learning-Based Discrimination of Treatment-Resistant Schizophrenia Using Structural Brain Imaging: A Multi-Site Proof-of-Concept Study.

Authors

Edgardo Torres-Carmona, Mario Graff-Guerrero, Shinichiro Nakajima, Yusuke Iwata, Fumihiko Ueno, Teruki Koizumi, Shiori Honda, Sakiko Tsugawa, Saki Homma, Kamiyu Ogyu, Ryosuke Tarumi, Jianmeng Song, Vincenzo Deluca, Gary Remington, Philip Gerretsen, Ariel Graff-Guerrero

Published in

Biological psychiatry. Aug 22, 2026. Epub Aug 22, 2026.

Abstract

Treatment-resistant schizophrenia (TRS) affects 20-30% of individuals with schizophrenia, with persistent symptoms, functional impairment, and reduced quality of life. Clinical identification remains dependent on sequential antipsychotic trials despite reported structural brain differences between TRS and treatment-responsive schizophrenia (TxR). This study evaluated whether structural MRI features could discriminate clinically defined TRS from TxR using machine learning.
A total of 225 participants (122 TRS, 103 TxR) from multi-site studies in Canada and Japan were included. Cortical thickness, brain volume, surface area, and intrinsic curvature were derived from T1-weighted MRI using FreeSurfer, with feature engineering generating volumetric-cortical thickness interaction terms. A voting ensemble was evaluated under a primary leakage-controlled NeuroComBat harmonization and a secondary exploratory full-dataset harmonization. Performance was assessed using ROC-AUC, F1 score, precision, and recall.
In the leakage-controlled analysis, the voting ensemble achieved a held-out ROC-AUC of 0.57 and macro F1 of 0.56; training cross-validation yielded ROC-AUC of 0.715. The full-dataset harmonization analysis yielded ROC-AUC of 0.60 and macro F1 of 0.62, interpreted cautiously due to leakage. Temporal-occipital cortical thickness and choroid plexus volume interaction terms contributed most to model performance.
Structural MRI features may support cross-sectional discrimination of TRS from TxR. The divergence between harmonization strategies highlights the importance of leakage-aware preprocessing in neuroimaging. Validation in independent cohorts is required to establish whether these features contribute to earlier identification of treatment resistance.

PMID:
42632582
Bibliographic data and abstract were imported from PubMed on 23 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.